The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review)

International Journal of Molecular Medicine

Volumn 32, Issue 4, 2013, Pages 747-754

  Ji, Ke ^a   Ye, Lin ^a   Mason, Malcolm D ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

G protein coupled receptor 54; Invasion and migration; Kiss 1; Kiss 1 receptor; Tumour metastasis suppressor

Indexed keywords

COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 54; GELATINASE B; KISSPEPTIN; KISSPEPTIN 10; KISSPEPTIN 13; KISSPEPTIN 14; METASTIN; UNCLASSIFIED DRUG;

BLADDER CANCER; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHROMOSOME 6; ENDOMETRIUM CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; FEEDBACK SYSTEM; GENOTYPE; HUMAN; KARYOTYPING; LIVER CELL CARCINOMA; MELANOMA; METASTASIS; MISMATCH REPAIR; NONHUMAN; OVARY CANCER; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE HOMOLOGY; STOMACH CANCER; SUPPRESSOR GENE; THYROID CANCER; TROPHOBLASTIC TUMOR; TUMOR SUPPRESSOR GENE;

CELL ADHESION; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KISSPEPTINS; LIGANDS; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84883438822     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1472     Document Type: Review

References (62)

1. McKay JA, Williams EA and Mathers JC: Effect of maternal and post-weaning folate supply on gene-specific DNA methylation in the small intestine of weaning and adult apc and wild type mice. Front Genet 2: 23, 2011.
2. Ohtaki T, Shintani Y, Honda S, et al: Metastasis suppressor gene Kiss-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411: 613-617, 2001.
3. Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C and Mundel P: Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome. Oncogene 22: 5298-5305, 2003.
4. Wang H, Jones J, Turner T, et al: Clinical and biological significance of KISS1 expression in prostate cancer. Am J Pathol 180: 1170-1178, 2012.
5. Cutait R, Calache JE, Borges JL, et al: The value of colonoscopy in low digestive hemorrhages of unexplained cause: analysis of 132 patients. Rev Paul Med 96: 66-68, 1980 (In Portuguese).
6. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480, 2006.
7. Lee JH, Miele ME, Hicks DJ, et al: KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88: 1731-1737, 1996.
8. Welch DR, Chen P, Miele ME, et al: Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9: 255-262, 1994.
9. Lee JH and Welch DR: Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer 71: 1035-1044, 1997.
10. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al: Kisspeptin?10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 117: 1319-1328, 2004.
11. Kotani M, Detheux M, Vandenbogaerde A, et al: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276: 34631-34636, 2001.
12. Miele ME, Jewett MD, Goldberg SF, et al: A human melanoma metastasis-suppressor locus maps to 6q16.3q23. Int J Cancer 86: 524-528, 2000.
13. Shirasaki F, Takata M, Hatta N and Takehara K: Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3q23. Cancer Res 61: 7422-7425, 2001.
14. Goldberg SF, Miele ME, Hatta N, et al: Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 63: 432-440, 2003.
15. Lee DK, Nguyen T, O'Neill GP, et al: Discovery of a receptor related to the galanin receptors. FEBS Lett 446: 103-107, 1999.
16. Muir AI, Chamberlain L, Elshourbagy NA, et al: AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276: 28969-28975, 2001.
17. Hori A, Honda S, Asada M, et al: Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 286: 958-963, 2001.
18. Lee JH and Welch DR: Suppression of metastasis in human breast carcinoma MDA-MB?435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57: 2384-2387, 1997.
19. Lee KH and Kim JR: KiSS-1 suppresses MMP?9 expression by activating p38 MAP kinase in human stomach cancer. Oncol Res 18: 107-116, 2009.
20. Yan C, Wang H and Boyd DD: KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. J Biol Chem 276: 1164-1172, 2001.
21. Ringel MD, Hardy E, Bernet VJ, et al: Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab 87: 2399, 2002.
22. Mitchell DC, Stafford LJ, Li D, Bar-Eli M and Liu M: Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein?1 and its coactivator DRIP?130. Oncogene 26: 1739-1747, 2007.
23. Marot D, Bieche I, Aumas C, et al: High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr Relat Cancer 14: 691-702, 2007.
24. Kostadima L, Pentheroudakis G and Pavlidis N: The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer. Anticancer Res 27: 2499-2504, 2007.
25. Stark AM, Tongers K, Maass N, Mehdorn HM and Held-Feindt J: Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131: 191-198, 2005.
26. Martin TA, Watkins G and Jiang WG: KiSS-1 expression in human breast cancer. Clin Exp Metastasis 22: 503-511, 2005.
27. Dhar DK, Naora H, Kubota H, et al: Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111: 868-872, 2004.
28. Yao HL, Yang ZL, Li YG and Liu GW: In situ hybridization study on the expression of KiSS-1 and KAI?1 metastasis suppressor genes in gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 10: 274-277, 2007 (In Chinese).
29. Tachibana M, Kinugasa S, Dhar DK, et al: Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus. Arch Surg 134: 50-54, 1999.
30. Ikeguchi M, Yamaguchi K and Kaibara N: Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res 10: 1379-1383, 2004.
31. Cedrone A, Rapaccini GL, Pompili M, et al: Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver 16: 94-98, 1996.
32. Hou YK, Wang Y, Cong WM and Wu MC: Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase?9 in portal vein tumor thrombus of hepatocellular carcinoma. Ai Zheng 26: 591-595, 2007 (In Chinese).
33. Ikeguchi M, Hirooka Y and Kaibara N: Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol 129: 531-535, 2003.
34. Schmid K, Wang X, Haitel A, et al: KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch 450: 143-149, 2007.
35. Rigaud G, Moore PS, Zamboni G, et al: Allelotype of pancreatic acinar cell carcinoma. Int J Cancer 88: 772-777, 2000.
36. Yatsuoka T, Sunamura M, Furukawa T, et al: Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma. Am J Gastroenterol 95: 2080-2085, 2000.
37. Masui T, Doi R, Mori T, et al: Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315: 85-92, 2004.
38. Liang S and Yang ZL: Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32: 109-113, 2007 (In Chinese).
39. Singer PA, Cooper DS, Daniels GH, et al: Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156: 2165-2172, 1996.
40. Stathatos N, Bourdeau I, Espinosa AV, et al: KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab 90: 5432-5440, 2005.
41. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 53: 5-26, 2003.
42. Jiang Y, Berk M, Singh LS, et al: KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis 22: 369-376, 2005.
43. Gao GL, Liu LD, Zou XS and Chen WX: Expression of KiSS-1, matrix metalloproteinase?9, nuclear factor-kappaBp65 in ovarian tumour. Zhonghua Fu Chan Ke Za Zhi 42: 34-38, 2007 (In Chinese).
44. Hata K, Dhar DK, Watanabe Y, Nakai H and Hoshiai H: Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer 43: 1452-1459, 2007.
45. Cole LA: Phantom hCG and phantom choriocarcinoma. Gynecol Oncol 71: 325-329, 1998.
46. Horikoshi Y, Matsumoto H, Takatsu Y, et al: Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 88: 914-919, 2003.
47. Cole LA and Sutton JM: Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. J Reprod Med 49: 545-553, 2004.
48. Dhillo WS, Savage P, Murphy KG, et al: Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab 291: E878-E884, 2006.
49. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
50. Nicolle G, Comperat E, Nicolaïew N, Cancel-Tassin G and Cussenot O: Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder. Ann Oncol 18: 605-607, 2007.
51. Buchan NC and Goldenberg SL: Intermittent androgen suppression for prostate cancer. Nat Rev Urol 7: 552-560, 2010.
52. Ramiah V, George DJ and Armstrong AJ: Clinical endpoints for drug development in prostate cancer. Curr Opin Urol 18: 303-308, 2008.
53. Plantade A, Massard C, de Crevoisier R and Fizazi K: Locally advanced prostate cancer: definition, prognosis and treatment. Bull Cancer 94: F50-F61, 2007 (In French).
54. Creasman WT, Odicino F, Maisonneuve P, et al: Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95 (Suppl 1): S105-S143, 2006.
55. Kang HS, Baba T, Mandai M, et al: GPR54 is a target for suppression of metastasis in endometrial cancer. Mol Cancer Ther 10: 580-590, 2011.
56. Nomura H, Sato H, Seiki M, Mai M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266, 1995.
57. Gottsch ML, Clifton DK and Steiner RA: Kisspepeptin-GPR54 signaling in the neuroendocrine reproductive axis. Mol Cell Endocrinol 254-255: 91-96, 2006.
58. Li D, Mitchell D, Luo J, et al: Estrogen regulates KiSS1 gene expression through estrogen receptor alpha and SP protein complexes. Endocrinology 148: 4821-4828, 2007.
59. Dissanayake SK, Wade M, Johnson CE, et al: The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 282: 17259-17271, 2007.
60. Ohta S, Lai EW, Pang AL, et al: Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer 114: 139-143, 2005.
61. Janneau JL, Maldonado-Estrada J, Tachdjian G, et al: Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 87: 5336-5339, 2002.
62. Jiang T, Zhang SL, Lin B, Meng LR and Gao H: Expression and clinical significance of KISS-1 and GPR54 mRNA in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi 27: 229-231, 2005 (In Chinese).